Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've had your first dose of semaglutide and you're wondering whether to carry on, you're not alone. Stopping semaglutide after one week is medically straightforward — one injection does not create physical dependence — but the decision itself is worth thinking through carefully, because the reasons people want to stop at this stage vary quite a bit, and so do the right responses. This page works through the main scenarios so you can make an informed choice, ideally with your prescriber's input.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common reason people consider stopping after a single dose is nausea, and occasionally vomiting, loose stools or a general sense of queasiness. These are real and they can be unpleasant, but the clinical picture is worth knowing. According to the NHS medicines page for semaglutide, gastrointestinal side effects are most noticeable when starting or after a dose increase, and they typically settle within days to a couple of weeks as your body adjusts.
The 0.25mg starting dose exists precisely to reduce this burden. It's a low, tolerability-focused step, your body's first introduction to a medicine that slows gastric emptying and changes how hunger signals arrive. Most people find the first few weeks are the hardest, and that things ease considerably once the system adapts.
Stopping at one week because of side effects is medically safe. But it may mean giving up before your body has had a fair chance to adjust. Before making that call, it's worth contacting your prescriber. There are practical strategies (eating smaller meals, avoiding fatty or spicy food, timing your injection around a quieter day) that can make a real difference. If side effects were severe or included anything concerning, that's a different conversation, and your prescriber needs to know.
One practical note: if you're logging the timing of your injections, many people find weekday mornings work well, keeping any rough 24-hour window away from a busy weekend.
If your reasons are more about second thoughts than side effects, that's entirely your call. Semaglutide is not physically addictive, and stopping after one dose carries no withdrawal risk. The medicine will clear from your system over several weeks, its half-life means concentration falls gradually rather than sharply.
What does change is the effect on appetite. While you're taking semaglutide, appetite suppression is active. Once you stop, hunger signals return to their previous pattern, typically within weeks. The clinical evidence on this is consistent: the STEP 1 trial, published in the New England Journal of Medicine, showed that participants who stopped semaglutide regained most of the weight they had lost within about a year. After just one week you won't have lost meaningful weight yet, so regain isn't the immediate concern, but if you're thinking about stopping Wegovy after weight loss, understanding the pattern of what happens next matters for long-term weight management.
For a fuller picture of what the evidence says about the period after stopping, our page on what happens after stopping Wegovy covers this in detail. And if bloating has been part of your experience, how bloating changes after stopping semaglutide addresses that specifically.
Sometimes people want to stop for a defined reason (a planned surgical procedure, a holiday, a period of illness) rather than permanently. This is different from deciding semaglutide isn't for you, and the clinical considerations differ too.
If surgery is the reason, NHS England's guidance on weight-management injections advises telling your healthcare team, including your anaesthetist, that you're taking a GLP-1 medicine before any procedure. Your prescriber may recommend stopping in advance; the timing depends on the specifics of the surgery, not a general rule.
If you're pausing for another reason and plan to restart, discuss that with your prescriber before you stop, not after. Depending on the gap, restarting at a lower dose may be appropriate, returning at a higher dose after a break can mean stronger side effects. The prescriber who reviewed your case is best placed to advise on this, and our guide to stopping Wegovy covers the practical considerations in more depth.
The cost context is also part of the decision for many people. If you're weighing up whether to continue treatment at all, our Wegovy price comparison page gives an honest view of what private treatment actually costs and what to look for in a provider. The right question isn't which service is cheapest, for a prescription medicine dispensed by a regulated pharmacy, the clinical oversight and supply chain matter more than headline pricing.
There are situations where stopping should be a clinical conversation, not a solo decision. If you experienced severe or persistent abdominal pain during your first week (especially pain that radiated to your back) you should contact a healthcare professional before making any decision about continuing. The MHRA's Drug Safety Update guidance on GLP-1 medicines flags acute pancreatitis as an infrequent but serious risk that warrants prompt attention if suspected.
Likewise, if you had an allergic reaction, or if any symptom felt out of proportion to normal adjustment effects, get medical advice. Yellow Card reporting at yellowcard.mhra.gov.uk is there for suspected adverse reactions, and reporting helps build the safety evidence base for everyone using these medicines.
If your situation is less urgent and you simply want to talk it through, our prescribers are available seven days a week. You can read more about how semaglutide works as a weight-loss medicine or explore the treatment options we offer before deciding what step makes sense for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.